Abstract

Here we investigate whether the presence of germinal vesicle-stage oocytes (GV− oocytes) reflects poor oocyte developmental competence (or quality). This was a prospective, non-randomised, cohort pilot-study involving 60 patients undergoing in vitro fertilization/ intracytoplasmic sperm injection for whom complete pregnancy outcome data were available. Patients in whom GV− oocytes were retrieved (GV+) at transvaginal oocyte retrieval (TVOR) were compared with those from whom no GVs were retrieved (GV−). We found that GV+ (n = 29) and GV− (n = 31) patients were similarly aged (35.4 vs. 36.4 years; p = 0.446). GV+ patients had a mean of 2.41 ± 2.03 GVs and comparable yields of MII oocytes to GV− patients (11 ± 6.88 vs. 8.26 ± 4.84; p = 0.077). Compared with GV− patients, GV+ patients had markedly lower implantation rates (11.8% vs. 30.2%; p = 0.022) as well as oocyte utilisation rates for clinical pregnancy (2.3% vs. 6.8%; p = 0.018) and live-birth (1.9% vs. 5.7%; p = 0.029). DNA damage levels measured using γH2AX immunostaining were not different in oocytes from women <36 years versus those ≥36 years (p = 0.606). Thus, patients who have GV− stage oocytes at TVOR exhibit poor oocyte quality reflected in reduced per-oocyte pregnancy success rates and uniformly high levels of oocyte DNA damage.

Highlights

  • Oocytes ovulated by women in their late 400 s would have been arrested in primordial follicles for a staggering 4–5 decades

  • Following hCG trigger during stimulated in vitro fertilization (IVF) cycles, typically around 70–85% of oocytes obtained at transvaginal oocyte retrieval (TVOR) are mature (MII-arrested) eggs with the other 15–30% being at MI- and GV− stages [7,8,9,10]

  • Our data based on clinical pregnancy outcomes and oocyte DNA damage levels suggest that the occurrence of GV− stage oocytes may be a surrogate marker for poor oocyte quality

Read more

Summary

A Pilot Study

Subramanian 1 , Jessica Greaney 1 , Chris Roling 2 , Jacqui Irving 2 and Hayden A. Reproductive Endocrinology & Infertility Clinic, Royal Brisbane & Women’s Hospital, Brisbane 4029, Queensland, Australia. Received: 21 November 2019; Accepted: 13 January 2020; Published: 16 January 2020

Introduction
Subjects
Ovarian Stimulation Protocol
Human Oocytes
Clinical Outcomes
Statistical Analyses
Overall Characteristics of Study Population and of Treatment Cycles
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call